Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1980-10-29
1981-10-20
Breitenstein, G. T.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424316, 424319, 560 37, 562442, 26050111, 2603268, 544107, 546184, A61K 3124, C07C101447, C07C101453
Patent
active
042961297
ABSTRACT:
Certain new propenamides and 2-butenamides having a (carboxyalkanamido)phenyl or a (carboxyalkenamido)phenyl group at the 3-position, and certain esters thereof, and their use for antagonizing the spasmogenic activity of slow-reacting substance of anaphylaxis (SRS-A) in a human subject. In particular, the compounds of the invention are useful for preventing and treating certain obstructive airways diseases, notably allergic bronchial asthma, allergic rhinitis and certain skin disorders, in human subjects.
REFERENCES:
patent: 625159 (1899-05-01), Einhorn
patent: 3993679 (1976-11-01), Hall et al.
patent: 4036837 (1977-07-01), Sellsted et al.
Breitenstein G. T.
Knuth Charles J.
Lumb J. Trevor
Pfizer Inc.
Richardson Peter C.
LandOfFree
(Carboxyacylamino)phenylalkenamides and esters thereof as SRS-A does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (Carboxyacylamino)phenylalkenamides and esters thereof as SRS-A , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (Carboxyacylamino)phenylalkenamides and esters thereof as SRS-A will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1491376